Fibrosis Models in Mice and Rats
Selecting preclinical in vivo models that are reflective of clinical outcome is a key challenge in the development of new...
Continue Reading
Selecting preclinical in vivo models that are reflective of clinical outcome is a key challenge in the development of new...
Continue Reading
Salt-inducible kinases (SIKs) have recently emerged as key regulators of oncogenesis, inflammation, and immune responses, making these enzymes an important...
Continue Reading
Atopic dermatitis (AD) is the most common, chronic inflammatory skin disease. To support drug discovery research in this area, WuXi...
Continue Reading
Our in vivo alopecia platform is comprised of both non-cicatricial and cicatricial alopecia models, including skin graft-induced alopecia areata (AA)...
Continue Reading
To characterize the immunity profile of the most widely used delayed-type hypersensitivity (DTH) models, WuXi AppTec scientists built 2,4-dinitrofluorobenzene (DNFB)...
Continue Reading
Providing a comprehensive panel of large animal disease models across multiple species, including NHP, mini-pig, dog, and rabbit. Models for...
Continue Reading
Comprehensive platform of over 40 disease models (including NHPs and other large animals), covering a wide range of indications and...
Continue Reading
We offer an extensive panel of inflammatory bowel disease models in mice and rats, including genetically modified, chemically induced, and...
Continue Reading
This webinar will focus on aspects related to PROTAC discovery and chemistry workflows, such as ligand finding strategies, synthesis optimization,...
Continue Reading